Please Wait

Applying Filters...

FDA approvals drop 24% in H1 2025; GSK’s UTI med, Vertex’s non-opioid painkiller lead pack of first-in-class meds

Data Compilation
#PharmaFlow

Pipeline Prospector August 2025: Novo’s Wegovy approved for MASH, Tonix Pharma’s fibromyalgia drug okayed

Stock Recap
#PipelineProspector

Ceftazidime Sodium

ACCESS ALL DATA, CHEMISTRY

ACTIVE PHARMA INGREDIENTS

44 API Suppliers, 18 USDMF, 16 CEP/COS, 6 JDMF, 3 EU WC, 4 KDMF, 4 NDC API, 17 Listed Suppliers, $ API Reference Price

DEVELOPMENTS

27 Drugs in Development

27 Drugs in Development

INTERMEDIATES

8 Intermediate Suppliers

8 Intermediate Suppliers

FINISHED DOSAGE FORMULATIONS

238 FDF Dossiers, 42 FDA Orange Book, 100 Europe, 6 Canada, 16 South Africa, 74 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

POWDER;INTRAVENOUS - EQ 0.5GM BASE;2GM/VIAL, INJECTABLE;INJECTION - 1GM/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, INJECTABLE;INJECTION - 2GM/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, INJECTABLE;INJECTION - 500MG/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, INJECTABLE;INJECTION - 6GM/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, INJECTABLE;INJECTION - EQ 20MG BASE/ML, INJECTABLE;INJECTION - EQ 40MG BASE/ML, INJECTABLE;INJECTION - EQ 1GM BASE, INJECTABLE;INJECTION - EQ 2GM BASE

RELATED EXCIPIENT COMPANIES

1 Kirsch Pharma, 1 Actylis, 1 Kerry, 1 Microlex e.U, 1 Pluviaendo, 1 Roquette

EXCIPIENTS BY APPLICATIONS

3 Parenteral, 2 Fillers, Diluents & Binders, 1 Taste Masking, 1 Chewable & Orodispersible Aids

DIGITAL CONTENT

25 News #PharmaBuzz

25 News #PharmaBuzz

GLOBAL SALES INFORMATION

5 US Medicaid Prescriptions, 82 Regulatory FDF Prices, 9 Annual Reports

MARKET PLACE

22 APIs, 20 FDF Dossiers

PATENTS & EXCLUSIVITIES

10 US Patents, 4 US Exclusivities

REF. STANDARDS & IMPURITIES

2 EDQM, 6 Others

$ Xls download

Filters

Log in to access your PharmaMiles and download the data

Last Updated on PharmaCompass	Virtual Booth	Country	Name of the Firm	Written Confirmation No.	Product Name	Issue Date	Valid Till	Address of the Firm
04/06/2025	Nectar Lifesciences	India	M/sNectar Lifesciences Limted	WC-0145	Ceftazidime for Injection USP/BP/Ph. Eur.	2022-11-18	2025-08-06	Unit-ll, Village-Saidpura, Tehsil-Derabassi, District-Sahibzada Ajit Singh Nagar, Punjab
06/09/2025	Orchid Pharma	India	M/s. Orchid Pharma Limited	WC-0131	Ceftazidime with sodium carbonate sterile for injectable formulation USP	01-08-2025	21-07-2028	Plot No.121-128, 128A-133,138-151 & 159-164,\nSIDCO Industrial Estate Alathur,\nChengalpattu-603110, Tamil Nadu India

Contact us
to update this info

Ceftazidime Sodium

Ceftazidime Sodium

ACCESS ALL DATA

Browse all information

CHEMISTRY

Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

44 API Suppliers

18 USDMF

16 CEP/COS

6 JDMF

3 EU WC

4 KDMF

4 NDC API

17 Listed Suppliers

$ API Reference Price

DEVELOPMENTS

27 Drugs in Development

INTERMEDIATES

8 Intermediate Suppliers

FINISHED DOSAGE FORMULATIONS

238 FDF Dossiers

42 FDA Orange Book

100 Europe

6 Canada

16 South Africa

74 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

POWDER;INTRAVENOUS - EQ 0.5GM BASE;2GM/VIAL

INJECTABLE;INJECTION - 1GM/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

INJECTABLE;INJECTION - 2GM/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

INJECTABLE;INJECTION - 500MG/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

INJECTABLE;INJECTION - 6GM/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

INJECTABLE;INJECTION - EQ 20MG BASE/ML

INJECTABLE;INJECTION - EQ 40MG BASE/ML

INJECTABLE;INJECTION - EQ 1GM BASE

INJECTABLE;INJECTION - EQ 2GM BASE

RELATED EXCIPIENT COMPANIES

1 Kirsch Pharma

1 Actylis

1 Kerry

1 Microlex e.U

1 Pluviaendo

1 Roquette

EXCIPIENTS BY APPLICATIONS

3 Parenteral

2 Fillers, Diluents & Binders

1 Taste Masking

1 Chewable & Orodispersible Aids

DIGITAL CONTENT

25 News #PharmaBuzz

GLOBAL SALES INFORMATION

5 US Medicaid Prescriptions

82 Regulatory FDF Prices

9 Annual Reports

MARKET PLACE

22 APIs

20 FDF Dossiers

PATENTS & EXCLUSIVITIES

10 US Patents

4 US Exclusivities

REF. STANDARDS & IMPURITIES

2 EDQM

6 Others

Filters

INJECTABLE;INJECTION - 1GM/VIAL Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons

INJECTABLE;INJECTION - 2GM/VIAL Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons

INJECTABLE;INJECTION - 500MG/VIAL Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons

INJECTABLE;INJECTION - 6GM/VIAL Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons